DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

BLSPOLY vs SUDARSHAN: Stock Comparison

BLS POLYMERS vs SUDARSHAN PHARMA INDUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

Metric snapshot

BLSPOLY leads 0; SUDARSHAN leads 0 of 4

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLSPOLYSUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹1,671 Cr
₹0 Cr
P/E RatioSame reading
—
28.27x
P/B RatioSame reading
—
4.11x
EPSSame reading
—
₹0.32
Book ValueContext only
—
₹6.14
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Price

MetricBLSPOLYSUDARSHAN
Live Price₹271.23₹32.71
Day Change15.54%0.03%
Volume6.26 Cr92,985
52-Week High₹288₹39.3
52-Week Low₹225₹31.01
Distance from 52W High-5.82%-16.77%

Valuation

MetricBLSPOLYSUDARSHAN
Market Cap₹1,671 Cr₹0 Cr
P/E Ratio—28.27x
P/B Ratio—4.11x
EPS—₹0.32
Book Value—₹6.14
Dividend Yield0%0%

Growth

MetricBLSPOLYSUDARSHAN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth—24.4%
Qtr Profit Growth—38.7%

Profitability & Leverage

MetricBLSPOLYSUDARSHAN
Net Margin0%0%

Shareholding

As of Sep 2026 • change vs previous quarter
MetricBLSPOLYSUDARSHAN
Promoter Holding—57.81%▼ 1.12 pp
FII Holding—21.95%▲ 2.57 pp
DII Holding—0%
Public Holding—20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLS POLYMERS and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.